Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session

  1. Home

  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W01--Effect of CFTR Modulator Therapy on Infection & Inflammation in CF
    Location: 156 A-C
    Chair: Emanuela M. Bruscia, PhD – Yale University
    Chair: Raul Rascon – Nationwide Children's Hospital
    IMIAPPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W02--Agnostic Avenues: Alternatives to CF Gene Therapy
    Location: 153 A-C
    Chair: Martina Gentzsch, PhD (she/her/hers) – University of North Carolina
    Chair: Nam Soo Joo – Stanford University
    APPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W01.1- Reduction in positive cultures for NTM and pulmonary disease in people with CF in the era of highly effective modulator therapy among participants in the longitudinal PREDICT study
    Location: 156 A-C
    Speaker: Stacey L. Martiniano, MD, MSCS (she/her/hers) – Childrens Hospital Colorado and University of Colorado
    IMIAPPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W01.2- Multi-lobe bronchoscopy reveals ETI’s effects on regional lung infection and inflammation
    Location: 156 A-C
    Speaker: Samantha Durfey, PhD (she/her/hers) – Emory University
    IMIAPPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W01.3- Integrative computational analysis of longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum microbiome and proteome in patients with cystic fibrosis
    Location: 156 A-C
    Speaker: Laura Schaupp, PhD (she/her/hers) – Charité-Universitätsmedizin Berlin
    IMIAPPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W01.4- Effect of elexacaftor/tezacaftor/ivacaftor treatment on metabolic shift of cystic fibrosis neutrophils
    Location: 156 A-C
    Speaker: Raul Rascon – Nationwide Children's Hospital
    IMIAPPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W01.5- Highly Effective Modulator Therapy reprograms CF lung cell immunometabolism
    Location: 156 A-C
    Speaker: Ying-Tsun Chen – Columbia University Irving Medical Center
    IMIAPPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W02.1- Anion-selective molecular prosthetics for CFTR outperform amphotericin B in cultured CF epithelia
    Location: 153 A-C
    Presenting Author: Daniel Greenan, BS (he/him/his) – University of Illinois Urbana-Champaign
    APPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W02.2- Primary mouse tracheal basal cells transplanted into CFTR-/- mice reconstitute CFTR function.
    Location: 153 A-C
    Speaker: Kevin Chen, MA – Center for Regenerative Medicine (CReM) / Boston University School of Medicine
    APPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W02.3- FOXI1 deletion alters ion transport and cellular composition in an iPSC-based airway system
    Location: 153 A-C
    Speaker: Stuart D. Rollins, MD (he/him/his) – Boston Children's Hospital
    APPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W02.4- Inhibition of Orai1 with ELD607 is immunomodulatory and reduces chronic lung disease in CF ferrets
    Location: 153 A-C
    Speaker: Maria Sassano, PhD – Eldec Pharmaceuticals
    APPTT
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    W02.5- Mechanistic insights into synergistic mucociliary clearance by combined adrenergic and cholinergic agonists
    Location: 153 A-C
    Speaker: Nam Soo Joo – Stanford University
    APPTT
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W09--Airway Ions, Fluid, & Mucus Transport
    Location: 109 AB
    Chair: Juan P. Ianowski, PhD (he/him/his) – University of Saskatchewan
    Chair: Ian Thornell – University of Iowa
    APPTT
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W09.1- Molecular Regulatory Pathways Associated with the Distinct Identities of Large and Small Airway Epithelia in Humans
    Location: 109 AB
    Speaker: Zoey Y. Wisniewski (she/her/hers) – University of North Carolina at Chapel Hill
    APPTT
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W09.2- Characterization of Ionocyte Subtypes in Cystic Fibrosis Ferret
    Location: 109 AB
    Speaker: Feng Yuan, PhD – University of Iowa
    APPTT
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W09.3- Progress towards studying CFTR channel regulation in different cell types in primary nasal epithelial cultures.
    Location: 109 AB
    Speaker: Tarini NA Gunawardena, PhD (she/her/hers) – Hospital for Sick Children
    APPTT
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W09.4- Dissecting the contribution of pulmonary ionocytes to surface airway liquid homeostasis
    Location: 109 AB
    Speaker: Javahir Hajibabazade, B.S. (she/her/hers) – The University of Iowa
    APPTT
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W09.5- Pulmonary ionocytes co-localize with goblet cells in the folds of small airway epithelium in swine
    Location: 109 AB
    Speaker: Xiaojie Luan, PhD (he/him/his) – University of Saskatchewan, Department of Anatomy, Physiology and Pharmacology
    APPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    LL02--Alveoli: A Player in the CF Lung?
    Location: 259 AB
    Chair: Wanda O'Neal – University of North Carolina at Chapel Hill Departments of Medicine and Genetics
    Chair: Raymond J. Pickles, PhD – University of North Carolina at Chapel Hill
    Speaker: Raymond J. Pickles, PhD – University of North Carolina at Chapel Hill
    Speaker: Wanda O'Neal – University of North Carolina at Chapel Hill Departments of Medicine and Genetics
    APPTTPTAC/CFTR
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02--Bugs & Drugs & Immunologic Thugs
    Location: Theater A (Exhibit & Poster Hall)
    Chair: Daniel Cook, MD, PhD – University of Iowa
    Chair: Sheryl Fernandes (she/her/hers) – Cedars Sinai Medical Center
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.1- Investigation of mechanisms enabling Streptococcus spp. persistence in polymicrobial CF infections
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Marta Rudzite, n/a (she/her/hers) – Geisel School Of Medicine at Dartmouth
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.3- Estimating the composition of the cystic fibrosis pulmonary microbiome
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Ameer Dharamshi, MSc (he/him/his) – University of Washington
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.4- Altered Hematopoiesis and Functional Decline of Hematopoietic Stem Cells in Cystic Fibrosis Mice
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Cassia L. Braga (she/her/hers) – Yale School of Medicine
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.5- Retarded Neutrophil Apoptosis Contributes to CF Neutrophilic Inflammation
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Yawen Hu – LSU Health Sciences Center
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.6- Lung-resident B- and T- cell responses limit AAV6.2 redelivery to the mouse lung
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Jay Kolls, MD – Tulane University School of Medicine
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.7- Tolerization of lymphocytes and dysregulation of low-density neutrophils are key features of PBMCs from patients with cystic fibrosis, following live Pseudomonas aeruginosa infection.
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Jean-Michel SALLENAVE (he/him/his) – INSERM U1152, Hôpital Bichat
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.8- Single-cell RNA sequencing of circulating peripheral blood mononuclear cells from people with cystic fibrosis and  nontuberculous mycobacteria pulmonary disease.
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Nicola I. Lore (he/him/his) – IRCCS Ospedale San Raffaele
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.9- Combined therapeutic strategies to favor the repair and regeneration of airway epithelium in cystic fibrosis despite the presence of bacterial infection
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Damien Adam (he/him/his) – Université de Montréal / CRCHUM
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.10- Aspergillus fumigatus germination is mucus concentration dependent, affected by modulator changes to sputum, and promoted by Th2 cytokine stimulation in Cystic Fibrosis
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: T. Spencer Poore, MD, MSCS (he/him/his) – University of Alabama at Birmingham
    IMIAPPTT
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    TPS02.2- Extracellular vesicle-mediated crosstalk in human cystic fibrosis airways concomitantly supports neutrophilic inflammation and epithelial resilience.
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Prashant Kumar, PhD (he/him/his) – Emory University
    IMIAPPTT
  • Thursday, Sep 26th
    2:30 PM – 4:30 PM ET
    S08--The Impact of Highly Effective Modulator Therapy on the Vicious Cycle of Obstruction, Infection, & Inflammation
    Location: 109 AB
    Chair: Deepika Polineni, MD MPH – Washington University in St. Louis
    Chair: Marcus A. Mall – Department of Pediatric Respiratory Medicine, Immunology and Intensive Care Medicine, Charité, Universitätsmedizin, Berlin, Germany
    Community Chair: Tré LaRosa
    APPTTIMI
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07--Lung Image Analysis to Measure CF Lung Disease
    Location: Theater B (Exhibit & Poster Hall)
    Chair: Zackary I. Cleveland, PhD (he/him/his) – Cincinnati Children's Hospital Medical Center
    Chair: Daan Caudri, MD, PhD (he/him/his) – Erasmus MC - Sophia Children's Hospital
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.1- Revealing dynamic air-flow abnormalities with high-resolution lung MRI
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Zackary I. Cleveland, PhD (he/him/his) – Cincinnati Children's Hospital Medical Center
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.2- Evaluation of Pulmonary Ventilation and Perfusion in Cystic Fibrosis Lung Disease using Functional Proton and Hyperpolarized Xe Magnetic Resonance Imaging
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Samal Munidasa – Cincinnati Childrens Hospital
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.3- Establishing a magnitude-independent minimum clinically important difference of hyperpolarized xenon-129 magnetic resonance ventilation imaging
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Vanessa M. Diamond, MSc (she/her/hers) – University of British Columbia
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.4- Determining the cross-platform interoperability of 129Xe ventilation MRI: Implications for multi-center clinical trials
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Rachel L. Eddy, PhD (she/her/hers) – University of British Columbia
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.5- Early Cystic Fibrosis Lung Disease Progression by Multiple-Breath Washout and Chest Magnetic Resonance Imaging
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Eva Steinke, MD (she/her/hers) – Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Germany
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.6- Longitudinal Evaluation of the Responsiveness of Hyperpolarized 129Xe Multiple-Breath Washout MRI to Elexacaftor/Tezacaftor/Ivacaftor Treatment in Pediatric Cystic Fibrosis
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Faiyza S. Alam (she/her/hers) – University of Toronto
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.7- Elexacaftor/tezacaftor/ivacaftor therapy improves lung clearance Index and magnetic resonance imaging scores in children with cystic fibrosis and one or two F508del alleles
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Mirjam Stahl, MD (she/her/hers) – Charité Universitätsmedizin, Berlin, Germany
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.8- ‘Silent' progression of lung disease in people receiving ETI therapy revealed by Oxygen Enhanced-MRI (OE-MRI)
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Christopher Short, MRes – Imperial College London
    APPTTCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W21--Airway Inflammation in CF: Molecules & Mechanisms
    Location: 109 AB
    Chair: Robert Gray
    Chair: Kristin Hudock, MD, MSTR – University of Cincinnati & Cincinnati Children's
    APPTT
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W21.1- CFTR Dysfunction Shapes Airway Immune Cell Compositions Contributing to Lung Pathogenesis in Children with CF
    Location: 109 AB
    Speaker: Tuba Kockar Kizilirmak, MD (she/her/hers) – Yale University
    APPTT
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    Inverse regulation of inflammasome and interferon mediators by human neutrophils adapted to the cystic fibrosis lung microenvironment
    Location: 109 AB
    Speaker: Deepali Luthra, PhD (she/her/hers) – Emory University
    APPTT
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W21.3- Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis
    Location: 109 AB
    Presenting Author: Domenico Mattoscio, PhD (he/him/his) – Università "G. d'Annunzio" Chieti - Pescara
    APPTT
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W21.4- TSLP and IL-33 alarmin cytokine production by primary human CF lung macrophages is induced by infection with Pseudomonas aeruginosa and further increased by CFTR modulators.
    Location: 109 AB
    Speaker: Daniel S. Aridgides, MD, PhD – Pulmonary/Critical Care
    APPTT
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W21.5- Elexacaftor/Tezacaftor/Ivacaftor Induces a Th2 Cytokine Increase in CF Sputum and Results in a Th1 to Th2 Class Switch in Airway Inflammation
    Location: 109 AB
    Speaker: T. Spencer Poore, MD, MSCS (he/him/his) – University of Alabama at Birmingham
    APPTT
  • Friday, Sep 27th
    2:30 PM – 4:30 PM ET
    S22--Finding an “Optimal” Dose in Drug Development: The Importance of Exposure/Response Relationships for Advancing Chronic CF Therapies
    Location: 210 A-C
    Chair: Donald R. VanDevanter, PhD – Case Western Reserve University School of Medicine
    Chair: Nicole Mayer Hamblett, PhD (she/her/hers) – University of Washington
    APPTTCLINPHARMPTAC/CFTR
  • Saturday, Sep 28th
    7:45 AM – 9:45 AM ET
    W32--Airway Differentiation, Pathogenesis, & Repair
    Location: 153 A-C
    Chair: Margarida Amaral – FCUL-Faculty of Sciences, University of Lisboa
    Chair: Vibha Lama, MD MS – Emory University, Atlanta, GA
    Chair: Gianni Carraro, PhD – Cedars-Sinai Medical Center
    APPTTPTAC/CFTR
  • Saturday, Sep 28th
    7:45 AM – 9:45 AM ET
    W32.1- Lef1 Induces Ionocyte Specification of Submucosal Gland Progenitors. Which One?
    Location: 153 A-C
    Speaker: Weam S A Shahin, MD PhD – University of Iowa
    APPTTPTAC/CFTR
  • Saturday, Sep 28th
    7:45 AM – 9:45 AM ET
    W32.2- Ionocytes localized in airway submucosal gland mucus tubule and ciliated ducts contribute to mucin unpacking
    Location: 153 A-C
    Speaker: Amirala Ostad Mohammad Nazari, BSc (he/him/his) – Department of Anatomy, Physiology and Pharmacology, University of Saskatchewan, Saskatoon, SK, Canada
    APPTTPTAC/CFTR
  • Saturday, Sep 28th
    7:45 AM – 9:45 AM ET
    W32.3- Temporal Dynamics in the Regulation of Pulmonary Ionocyte Development through NOTCH Signaling
    Location: 153 A-C
    APPTTPTAC/CFTR
  • Saturday, Sep 28th
    7:45 AM – 9:45 AM ET
    W32.4- ELD607, an Orai1 antagonist, reverses goblet cell metaplasia in βENaC mice.
    Location: 153 A-C
    Speaker: Saira Ahmad, PhD – Eldec Pharmaceuticals
    APPTTPTAC/CFTR
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06--Pre-Clinical Models of CF Organ Disease
    Location: Theater A (Exhibit & Poster Hall)
    Chair: Rabindra Tirouvanziam, PhD (he/him/his) – Department of Pediatrics, Emory University
    Chair: Eszter K. Vladar, PhD – University of Colorado School of Medicine
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.1- Hillocks are injury-resistant reservoirs of rare plastic stem cells in mouse and human airways
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Viral Shah – MGH
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.2- iBC-Direct Thaw Protocol: A facile method to generate reproducible iPSC-derived air-liquid-interface cultures
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Junjie Lu, PhD (he/him/his) – Cystic Fibrosis Foundation
    Speaker: John E. Mahoney – Cystic Fibrosis Foundation Therapeutics Lab
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.3- Combining device and tissue engineering towards an ex vivo airway model of cystic fibrosis lung disease.
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Yuliang Xie (he/him/his) – Department of Biomedical Engineering, University of Iowa
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.4- Bioengineered 3D CF lung airway model for drug testing
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Hoyeol Kim, PhD – Cedars-Sinai Medical Center
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.5- Rescue of PiZ alpha1-antitrypsin by ERp29 in C. elegans
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Anyesha Sarkar (she/her/hers) – Washington University school of Med
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.6- Development of mouse models of bronchiectasis
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Alessandra Livraghi-Butrico, PhD (she/her/hers) – University of North Carolina at Chapel Hill Marsico Lung Institute
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.7- Characterizing small airway epithelia in cystic fibrosis ferrets with CFTR G551D mutations by bulk RNA-sequencing
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Angela Peraino, DO – Corewell Health West/Michigan State University College of Human Medicine
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.8- Airway surface as a battleground for epithelial cells against bacteria
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Daniela Guidone, PhD (she/her/hers) – Telethon Institute of Genetics and Medicine (TIGEM)
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.9- The impact of diesel exhaust particles on cystic fibrosis lung disease
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Elizabeth Kramer, MD, PhD – Cincinnati Children's Hospital
    APPTT
  • Saturday, Sep 28th
    8:15 AM – 9:45 AM ET
    TPS06.10- Targeting cellular senescence in the cystic fibrosis lung.
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Emma L. Matthews (she/her/hers) – The University of Alabama at Birmingham
    APPTT
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W35--Lung Transplantation & Pulmonary Vascular Biology
    Location: 109 AB
    Chair: Keven Mara Robinson, MD (she/her/hers) – University of Pittsburgh
    Chair: Don Hayes, Jr., MD (he/him/his) – Cincinnati Children's Hospital Medical Center
    Community Chair: Dylan Mortimer, Bachlor in Fine Arts, Masters in Fine Arts (he/him/his) – Dylan Mortimer Art
    APPTT
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W35.1- Lung Transplant Referral Guidelines for Individuals with Cystic Fibrosis
    Location: 109 AB
    Speaker: Kathleen J. Ramos, MD MS (she/her/hers) – University of Washington
    APPTT
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W35.2- The changing transplant landscape in the era of elexacaftor/tezacaftor/ivacaftor: a word of caution
    Location: 109 AB
    Speaker: Cecilia Chaparro, MD (she/her/hers) – Toronto General Hospital/ St. Michael's Hospital, Toronto
    APPTT
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W35.3- Gene Expression Alterations in Lung Allografts with Acute Cellular Rejection
    Location: 109 AB
    Speaker: Andrew S. Potter, MS (he/him/his) – Cincinnati Children's Hospital Medical Center
    APPTT
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W35.4- Role of pharmacogenomics in lung transplant with CF and Elexacaftor/Tezacaftor/Ivacaftor therapy
    Location: 109 AB
    Speaker: Aderajew Taddesse, MD, MSc, GCSRT – Brigham and Women’s Hospital (BWH) /Harvard Medical School
    APPTT
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W35.5- Individualized Lung Transplant Care with Biomarkers for CLAD
    Location: 109 AB
    Speaker: Assem Ziady, PhD – Cincinnati Childrens Hospital
    APPTT
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT1-APPTT: CFTR Therapeutics in the Real World: Impact of the Environment on Efficacy
    Location: 204 B
    Facilitator: Elizabeth Kramer, MD, PhD – Cincinnati Children's Hospital
    APPTT
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT2-APPTT: Bronchoscopy as a Clinical & Research Tool in CF
    Location: 204 B
    Facilitator: Alix Ashare, MD PhD – Geisel School of Medicine at Dartmouth
    APPTT
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT7-APPTT: The Biologic Therapies in CF
    Location: 208
    Facilitator: Alicia A. Mirza, MD (she/her/hers) – Stanford University School of Medicine
    APPTT
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT8-APPTT: The Impact of Calcium Signaling Regulation on CFTR
    Location: 208
    Facilitator: Yunjie Huang, PhD – Indiana University
    APPTT